BridgeMD
New treatment option for Intensive Care Unit Acquired Weakness
Official title Technology-Assisted Early Mobilization Program Among Patients in the Intensive Care Units
ClinicalTrials.gov ID: NCT06700694
What this study is testing
- What it's testing
- This single-blind, three-group parallel randomized controlled trial will involve 138 patients with critical illness, randomly assigned at a 1:1:1 ratio to the technology-assisted early mobilization group (46 patients), the systematic early mobilization group (46 patients), or the control group (46 patients). The technology-assisted early mobilization group will receive interventions within 72 hours of ventilator use.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged ≥ 18 years
- Being mechanically ventilated ≥ 24 hours
- Richmond Agitation-Sedation Scale (RASS): 0 to -1
- No vision, hearing, or body movements restriction
- With clear consciousness and ability to communicate in Chinese
You likely can't join if
- Have developed delirium before enrollment (ICDSC \> 4)
- With acute physiology and chronic health evaluation (APACHE II) score \> 25 after ICU admission within 24 hours
- With muscle weakness caused by severe acute brain injury (e.g., traumatic brain injury or stroke), spinal coral injury, other neuromuscular...
See the full eligibility criteria
- Aged ≥ 18 years
- Being mechanically ventilated ≥ 24 hours
- Richmond Agitation-Sedation Scale (RASS): 0 to -1
- No vision, hearing, or body movements restriction
- With clear consciousness and ability to communicate in Chinese
- Expected to stay in the ICU \> 96 hours.
- Have developed delirium before enrollment (ICDSC \> 4)
- With acute physiology and chronic health evaluation (APACHE II) score \> 25 after ICU admission within 24 hours
- With muscle weakness caused by severe acute brain injury (e.g., traumatic brain injury or stroke), spinal coral injury, other neuromuscular conduction diseases, or long-term bedridden or hemiplegia.
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.